Search Within
Applied Filters:
Keyword:'y0000768'
Showing 1-30 of 47 results for "

y0000768

" within Papers
Etodolac: the chemistry, pharmacology, metabolic disposition, and clinical profile of a novel anti-inflammatory pyranocarboxylic acid.
L G Humber
Medicinal research reviews, 7(1), 1-28 (1987-01-01)
Yuki Kutsuno et al.
Drug metabolism and disposition: the biological fate of chemicals, 42(7), 1146-1152 (2014-04-26)
UDP-glucuronosyltransferases (UGTs) are phase II drug-metabolizing enzymes that catalyze glucuronidation of various drugs. Although experimental rodents are used in preclinical studies to predict glucuronidation and toxicity of drugs in humans, species differences in glucuronidation and drug-induced toxicity have been reported....
Tetsuji Takayama et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 17(11), 3803-3811 (2011-03-10)
On the basis of the results of our preliminary trial suggesting that aberrant crypt foci (ACF) could be eradicated by short-term administration of sulindac, in the present study, we explored the feasibility of using ACF as surrogate markers for chemoprevention...
Katsuhito Miyazawa et al.
International journal of urology : official journal of the Japanese Urological Association, 19(10), 936-943 (2012-05-30)
To determine the roles of endogenous cyclooxygenase 2 and prostaglandin E(2) in crystal-cell binding, which is considered to be an important step in the development of intratubular nephrocalcinosis. An expression plasmid for human cyclooxygenase 2 was introduced into Madin-Darby canine...
Naoki Inoue et al.
Pharmacology, 90(1-2), 47-54 (2012-06-29)
The excitability of nociceptors is modulated by the transient receptor potential cation channel, ankyrin subfamily, member 1 (TRPA1). We have previously reported that etodolac, a nonsteroidal anti-inflammatory drug, attenuates mechanical allodynia in a mouse model of neuropathic pain by a...
Ahmed Abd-Elbary et al.
AAPS PharmSciTech, 12(2), 485-495 (2011-04-12)
The aim of the current work was the design and evaluation of etodolac controlled porosity osmotic pump (CPOP) tablets exhibiting zero-order release kinetics. Variables influencing the design of (1) core tablets viz., (a) osmogent type (sodium chloride, potassium chloride, mannitol...
Shogo Murata et al.
Anticancer research, 31(9), 2893-2898 (2011-08-27)
5-Fluorouracil (5-FU) is widely used in the treatment of head and neck squamous cell carcinoma (HNSCC). However, development of drug resistance is one of the major causes of HNSCC treatment failure. The goal of this study was to investigate the...
Indemonstrable axial spondyloarthritis: does it exist?
Gleb Slobodin et al.
The Israel Medical Association journal : IMAJ, 15(12), 780-781 (2014-01-24)
Yukiko Nozawa et al.
Clinical and experimental nephrology, 16(2), 221-230 (2011-12-08)
There is increasing evidence that a change in glomerular hemodynamics may promote the development of glomerulosclerosis. In this study, we focused on the pharmacological effects of 2 contrasting agents, etodolac, a preferential cyclooxygenase-2 inhibitor, and beraprost sodium (BPS), a prostaglandin...
Aldona Majcher et al.
Analytica chimica acta, 855, 51-59 (2014-12-30)
We determine the association constants for ligand-protein complex formation using the flow injection method. We carry out the measurements at high flow rates (F=1 mL min(-1)) of a carrier phase. Therefore, determination of the association constant takes only a few...
M Pena
Rheumatology international, 10 Suppl, 9-16 (1990-01-01)
Numerous clinical trials have shown etodolac to be an effective analgesic. The purpose of the present report is to review results of 14 studies that demonstrate the effectiveness of etodolac in a variety of painful conditions. Presented are the results...
Z Adhim et al.
British journal of cancer, 105(3), 393-402 (2011-07-14)
Although the anti-tumour effect of cyclooxygenase-2 (Cox-2) inhibitors in invasive bladder cancer has been confirmed, its mechanisms of action are unclear. Recently, the concept of an epithelial-to-mesenchymal transition (EMT) promoting carcinoma progression has been suggested, and a key feature of...
V Ellerkamp et al.
Pediatric surgery international, 29(2), 141-149 (2012-12-26)
The proto-oncogene beta-catenin is linked to an abnormal activation of the Wnt/beta-catenin-pathway and shows mutations in 50-90 % of hepatoblastoma (HB). Corresponding, the recently published murine orthotopic HB model differs from the former subcutaneous model by nuclear beta-catenin distribution. As the...
D M Dvornik
The Journal of rheumatology. Supplement, 47, 40-47 (1997-02-01)
Inflammation is a complex process involving numerous mediators. Because prostaglandins (PG) have been implicated as mediators in all stages of inflammation, inhibition of their synthesis provides the basis for the therapeutic effects of nonsteroidal antiinflammatory drugs (NSAID). Treatment with NSAID...
Soad S Abd el-Hay et al.
Journal of fluorescence, 22(1), 247-252 (2011-08-20)
A simple, selective and sensitive luminescence method has been developed for the assay of etodolac (I), moxepril HCl (II) and fexofenadine HCl (III) in bulk drug and pharmaceutical formulations. The method is based on the luminescence sensitization of europium (Eu(3+))...
Vesile Öztürk et al.
Pain practice : the official journal of World Institute of Pain, 13(3), 191-197 (2012-06-27)
We aimed to determine the efficacy and safety of etodolac, in acute migraine attacks in comparison with paracetamol (acetaminophen). We designed a randomized, double-blind, crossover phase III clinical trial for patients diagnosed with migraine for at least 1 year, according...
Yuuki Akagi et al.
Biological & pharmaceutical bulletin, 34(2), 233-237 (2011-03-19)
Low-dose aspirin acts by irreversibly acetylating internal cyclooxygenase-1 (COX-1) on platelets, thereby suppressing platelet aggregation. Because nonsteroidal anti-inflammatory drugs (NSAIDs) also inhibit COX-1, the antiplatelet effects of aspirin may be suppressed when it is co-administered with NSAIDs. In this study...
Naoyoshi Nagata et al.
Journal of gastroenterology and hepatology, 30(2), 292-298 (2014-10-24)
The associations between antithrombotic or antihypertensive drugs and peptic ulcer bleeding (PUB) remain unknown, particularly in Asia, where Helicobacter pylori infection is prevalent. This study aims to evaluate the risks of PUB from antithrombotic drugs, angiotensin II receptor blockers (ARBs)...
D R Brocks et al.
Clinical pharmacokinetics, 26(4), 259-274 (1994-04-01)
Etodolac is a chiral nonsteroidal anti-inflammatory drug (NSAID) that is marked as the racemate. Currently, the drug is available in several countries for the treatment of arthritis and the alleviation of pain. Etodolac possesses several unique disposition features mainly due...
Cheong Hoon Lee et al.
Talanta, 129, 552-559 (2014-08-17)
Because of the high stability and potential toxic effects of non-steroidal anti-inflammatory drugs (NSAIDs), it is important to closely monitor their concentrations in the environment using a sensitive analytical method. In this study, a simple, rapid, efficient, and sensitive analytical...
Kathryn K Surdyk et al.
American journal of veterinary research, 73(9), 1485-1490 (2012-08-29)
To determine the effects of carprofen and etodolac on renal function in euvolemic dogs and dogs with extracellular fluid volume depletion induced via administration of furosemide. 12 female Beagles. Dogs received a placebo, furosemide, carprofen, etodolac, furosemide and carprofen, and...
Acute generalized exanthematous pustulosis due to etodolac in a patient with an iliopsoas muscle abscess.
Yoshitaka Nakamura et al.
Acta dermato-venereologica, 91(5), 589-590 (2011-06-02)
Yael Goldfarb et al.
Annals of surgery, 253(4), 798-810 (2011-04-09)
Surgical procedures, including primary tumor resection, have been suggested to suppress immune competence and to promote postoperative infections and cancer metastasis. Catecholamines and prostaglandins were recently implicated in these processes, and in directly promoting tumor angiogenesis and invasion. To examine...
A Karbowski
Clinical rheumatology, 8 Suppl 1, 73-79 (1989-03-01)
Etodolac has previously been reported to have an excellent safety profile. Results of recent clinical trials and of a clinical practice study were compared with the previously reported safety data for etodolac. The total incidence of patient complaints and of...
Toxic epidermal necrolysis complicated by sepsis, haemophagocytic syndrome, and severe liver dysfunction associated with elevated interleukin-10 production.
Toshifumi Yamaoka et al.
European journal of dermatology : EJD, 22(6), 815-817 (2012-11-28)
G Santra et al.
Singapore medical journal, 51(11), 883-887 (2010-12-09)
Bisphosphonates have anti-inflammatory properties in arthritic conditions. This study was conducted to assess the therapeutic potential of intravenous pamidronate in nonsteroidal anti-inflammatory drug (NSAID) refractory/intolerant cases of ankylosing spondylitis (AS). A total of 35 NSAID refractory/intolerant AS patients with Bath...
Jun Takahashi et al.
Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 18(2), 208-215 (2012-12-04)
Quality of life (QOL) is a concern for patients with lumbar spinal stenosis (LSS). In this study, QOL was examined using the 5-item EuroQol (EQ-5D). QOL and activities of daily living (ADL) were surveyed for 91 patients who visited 18...
Naoki Inoue et al.
Biological & pharmaceutical bulletin, 34(5), 655-659 (2011-05-03)
The anti-inflammatory agent etodolac is used worldwide and it has a good gastrointestinal safety profile. Etodolac consists of two enantiomers, S- and R-etodolac. Here, we investigated the beneficial activities of racemic etodolac and its enantiomers. First, we compared S- and...
Magdy M Ibrahim et al.
AAPS PharmSciTech, 11(4), 1730-1737 (2010-12-08)
Etodolac (ET) is a nonsteroidal anti-inflammatory drug with proved potential antitumor and uric acid lowering effects. It shows dissolution rate-dependent bioavailability. This work was carried out to improve the dissolution rate of etodolac using three carriers of known potential to...
S Lynch et al.
Drugs, 31(4), 288-300 (1986-04-01)
Etodolac is a new non-steroidal agent (NSAID) with anti-inflammatory and analgesic activity. It has been studied in rheumatoid arthritis, osteoarthritis, and pain resulting from minor surgery. In the latter setting, etodolac is at least as effective as aspirin in terms...
Page 1 of 2
Page 1 of 2